FDA Clearance Tracker · P200031-S007
Organ Care System (OCS) Liver
Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 13, 2025
Approved
Time to decision
179 days
Received Jul 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P200031-S007
- Device name
- Organ Care System (OCS) Liver
- Applicant
- TransMedics, Inc.
- Applicant location
- Andover, MA
- Received
- Jul 18, 2024
- Decided
- Jan 13, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P200031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the implementation of an alternative oxygenator, identified as the Maquet Quadrox-i, for the Organ Care System Liver
Source documents
Other decisions for TransMedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231362 · Decided Oct 31, 2023 · 173 days after receipt
Device type: Filter, Blood, Cardiopulmonary Bypass, Arterial Line (DTM) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.